Log in Book a Demo

US Pharma & Biotech Oncology - PPC Market Share Analysis March 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Oncology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Oncology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Domain Share of clicks
letschatcart.com 6.45
cancer.org 6.06
breyanzi.com 4.16
cityofhope.org 3.83
mayoclinic.org 2.72
abecma.com 2.31
mmissionpossible.com 2.27
breastcancer.org 2.14
nubeqa-us.com 2.11
tnbcfoundation.org 2.02
others 65.93

Copyright © Adthena. All rights reserved.

In the oncology PPC landscape, “others” dominate with 65.93% click share. “Letschatcart.com” and “cancer.org” follow with 6.45% and 6.06%, respectively.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Oncology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Date nubeqa-us.com breyanzi.com trodelvy.com abecma.com cancer.org letschatcart.com cityofhope.org her2empowered.com her2know.com kisqali.com
2025/03/01 4.4% 1.19% 2.39% 1.99% 1.27% 2.2% 0.53% 1.41% 1.31% 11.29%
2025/03/02 3.68% 1.98% 1.49% 1.62% 1.44% 2.88% 0.4% 2.36% 1.18% 12.56%
2025/03/03 3.65% 2.39% 1.96% 0.84% 1.24% 2.19% 2.03% 1.93% 0.82% 15.8%
2025/03/04 4.49% 2.16% 3.58% 3.24% 1.1% 2.83% 2.66% 3.44% 1.55% 6.86%
2025/03/05 6.26% 5.05% 5.79% 2.99% 2.17% 3.69% 4.7% 3.85% 2.25% 1.04%
2025/03/06 5.24% 3.17% 4.07% 2.43% 3.85% 3.71% 4.96% 4.45% 1.92% 0.47%
2025/03/07 4.02% 4.11% 3.3% 2.61% 5.78% 1.37% 4.29% 3.22% 2.38% 1.03%
2025/03/08 2.74% 4.35% 3.24% 3.09% 4.81% 2.49% 1.22% 2.1% 3.27% 2.25%
2025/03/09 8.9% 2.87% 2.89% 2.95% 3.97% 5.29% 1.08% 2.45% 3.06% 0.77%
2025/03/10 5.52% 4.53% 3.4% 3.83% 4.2% 4.54% 8.67% 2.39% 3.29% 0.37%
2025/03/11 7.62% 5.39% 6.15% 3.84% 1.55% 5.06% 9.48% 2% 2.1% 0.41%
2025/03/12 6.7% 4.77% 3.98% 3.85% 4.24% 3.35% 7.27% 3.09% 3.86% 0.18%
2025/03/13 7.3% 3.17% 4.19% 2.81% 5.18% 4.65% 6.67% 2.21% 2.32% 0.19%
2025/03/14 7.13% 4.03% 4% 3.41% 2.43% 4.06% 6.33% 1.5% 3% 0.22%
2025/03/15 9.33% 4.69% 5.19% 3.54% 3.17% 2.88% 1.81% 2.73% 3.14% 0.29%
2025/03/16 7.19% 4.28% 3.53% 3.68% 8.87% 3.7% 1.19% 1.79% 1.79% 0.21%
2025/03/17 12.47% 4.98% 3.88% 3.63% 3.56% 3.26% 6.63% 3.65% 3.52% 0.25%
2025/03/18 6.37% 4.78% 5.48% 3.18% 1.43% 2.96% 6.79% 2.63% 4.48% 0.2%
2025/03/19 5.02% 4.58% 5.03% 4.93% 4.2% 3.96% 4.69% 2.8% 3.26% 0.21%
2025/03/20 10.21% 5.86% 5.55% 5.65% 1.71% 5.54% 8.73% 2.94% 3.45% 0.26%
2025/03/21 7.72% 5.26% 4.79% 3.17% 2.57% 4.04% 5.86% 1.79% 2.37% 0.19%
2025/03/22 6.02% 3.27% 3.92% 3.71% 4.4% 3.86% 0.99% 1.88% 3.24% 0.16%
2025/03/23 8.08% 7.13% 2.83% 3.71% 2.94% 2.78% 1.09% 1.73% 3.02% 0.24%
2025/03/24 8.74% 4.03% 3.42% 4.14% 2.31% 3.87% 7.47% 2.35% 2.02% 0.18%
2025/03/25 9.62% 5.61% 4.67% 3.35% 2.61% 5.51% 4.21% 1.77% 3.08% 0.17%
2025/03/26 8.32% 6.19% 4.24% 3.49% 2.29% 3.89% 6.7% 2.38% 3.14% 0.17%
2025/03/27 6.69% 5.6% 4.73% 3.79% 3.33% 4.4% 5.09% 1.84% 2.95% 0.16%
2025/03/28 5.52% 6.48% 4.13% 2.96% 3.55% 3.4% 2.99% 1.71% 1.35% 0.15%
2025/03/29 7.63% 6.21% 3.89% 3.18% 5.23% 2.92% 1.1% 1.19% 0.66% 0.19%
2025/03/30 7.48% 5.55% 4.07% 3.89% 5.59% 4.62% 0.79% 0.66% 0.65% 0.2%
2025/03/31 8.39% 6.93% 5.52% 4.1% 3.66% 2.32% 1.32% 1.13% 1.1% 0.23%

Copyright © Adthena. All rights reserved.

March saw dynamic shifts in PPC spend share. Nubeqa-us.com peaked mid-month, while breyanzi.com and trodelvy.com showed steady growth. Kisqali.com started strong but declined. The month ended with diverse spend patterns across domains.

Market Exposure

Competitor Count for US Pharma & Biotech Oncology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Date Competitor Count
2025/03/01 454
2025/03/02 434
2025/03/03 438
2025/03/04 426
2025/03/05 425
2025/03/06 453
2025/03/07 465
2025/03/08 463
2025/03/09 411
2025/03/10 426
2025/03/11 406
2025/03/12 415
2025/03/13 405
2025/03/14 397
2025/03/15 352
2025/03/16 326
2025/03/17 314
2025/03/18 336
2025/03/19 340
2025/03/20 321
2025/03/21 336
2025/03/22 351
2025/03/23 317
2025/03/24 324
2025/03/25 318
2025/03/26 335
2025/03/27 350
2025/03/28 344
2025/03/29 341
2025/03/30 347
2025/03/31 353

Copyright © Adthena. All rights reserved.

March began with 454 advertisers, peaking at 465 on the 7th. A decline followed, reaching 314 on the 17th. The month concluded with a slight recovery, ending at 353 advertisers.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Oncology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Name Market Trend
myeloma.org 1.75%
yourattentionplease.com 1.69%
breyanzi.com 1.47%
letschatcart.com 0.88%
themmrf.org 0.75%
clevelandclinic.org -0.93%
keytruda.com -1%
breastcancer.org -1.69%
cancer.org -1.69%
rethinkbreastcancer.com -2.12%

Copyright © Adthena. All rights reserved.

Myeloma.org leads with a 1.75% click share rise, while rethinkbreastcancer.com drops by 2.12%.

Campaign Efficiency

US Pharma & Biotech Oncology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date breyanzi.com letschatcart.com cancer.org envita.com abecma.com mayoclinic.org cityofhope.org her2know.com her2empowered.com mmissionpossible.com
2025/03/01 0.7% 8.32% 1.78% 0.91% 1.55% 3.22% 0.75% 1.97% 2.2% 2.99%
2025/03/02 2.28% 9.76% 2.88% 1% 2.65% 1.13% 0.76% 1.56% 3.02% 1.86%
2025/03/03 3.47% 8.33% 1.15% 1.13% 0.7% 5.71% 3.28% 1.28% 2.77% 2.25%
2025/03/04 2.2% 9.69% 1.43% 0.81% 3.85% 1.36% 4.97% 1.99% 4.34% 2.07%
2025/03/05 4.72% 9.49% 1.97% 1.42% 1.67% 0.87% 5.33% 2.46% 3.77% 0.43%
2025/03/06 2.5% 7.32% 2.92% 2.06% 1.43% 1.83% 4.61% 1.72% 3.71% 4.14%
2025/03/07 4% 2.99% 4.8% 2.07% 2.51% 1.61% 4.28% 2.47% 3.13% 1.8%
2025/03/08 4.08% 5.14% 4.03% 2.06% 3.05% 0.92% 1.13% 2.97% 1.66% 3.49%
2025/03/09 3.1% 13.46% 4.2% 3.53% 1.64% 3.21% 1.22% 3.36% 2.28% 0.18%
2025/03/10 3.5% 9.86% 3.34% 2.58% 2.54% 1.35% 9.82% 2.9% 1.86% 2.03%
2025/03/11 4.36% 11.32% 1.37% 1.59% 3.87% 1.62% 10.18% 1.88% 1.6% 7.64%
2025/03/12 4.75% 8.5% 3.48% 1.01% 3.35% 1.63% 7.06% 3.47% 2.53% 3.79%
2025/03/13 2.34% 10.71% 3.56% 1.39% 1.48% 1.33% 6.58% 2.13% 1.73% 2.39%
2025/03/14 3.06% 8.33% 1.32% 2.67% 1.65% 0.97% 7.41% 2.48% 1.1% 5.63%
2025/03/15 3.6% 6.55% 2.44% 3.53% 1.59% 2.12% 1.91% 3.32% 2.48% 3.47%
2025/03/16 3.8% 8.5% 6.23% 3.34% 3.22% 2.93% 0.9% 1.98% 1.62% 0.4%
2025/03/17 5.52% 10.13% 3.93% 1.45% 1.82% 3.17% 6.84% 3.63% 3.47% 0.21%
2025/03/18 4.43% 7.34% 1.19% 1.67% 2.07% 0.56% 8.07% 4.14% 2.12% 0.24%
2025/03/19 3.31% 7.8% 2.72% 1.72% 5.67% 0.62% 4.36% 2.63% 2.09% 8.25%
2025/03/20 5.24% 15.63% 1.58% 2.15% 4.89% 1.62% 9.77% 3.87% 2.79% 3.23%
2025/03/21 4.36% 9.08% 2.34% 2.78% 1.52% 0.98% 5.71% 2.22% 1.28% 4.51%
2025/03/22 2.6% 8.96% 3.8% 2.04% 2.72% 1.41% 0.8% 2.98% 1.51% 3.19%
2025/03/23 7.08% 6.94% 2.98% 1.97% 1.35% 5.48% 0.8% 3.51% 1.73% 0.13%
2025/03/24 2.41% 8.82% 2.85% 2.08% 4.34% 1.55% 6.72% 1.64% 1.88% 5.92%
2025/03/25 5.45% 13.61% 2.28% 2.81% 1.05% 1.51% 4.04% 3.14% 1.56% 0.41%
2025/03/26 6.63% 9.51% 1.57% 2.08% 1.5% 2.22% 6.66% 3.05% 2.07% 2.48%
2025/03/27 5.37% 10.49% 2.88% 1.92% 2.9% 1.6% 5.35% 2.69% 1.53% 2.17%
2025/03/28 5.93% 7.33% 2.51% 1.24% 1.6% 1.84% 1.69% 1.15% 1.38% 6.7%
2025/03/29 6.34% 7.31% 4.24% 0.83% 1.65% 3.91% 1.15% 0.65% 1.03% 2.52%
2025/03/30 5.38% 11.68% 3.84% 3.42% 1.78% 1.43% 0.8% 0.73% 0.59% 3.02%
2025/03/31 7.09% 5.32% 3.87% 3.78% 1.51% 1.33% 1.25% 1.23% 1.11% 0.2%

Copyright © Adthena. All rights reserved.

In March 2025, breyanzi.com saw a steady rise in PPC impressions, peaking at 7.09% on the 31st. Meanwhile, letschatcart.com fluctuated, reaching a high of 15.63% on the 20th. Cancer.org maintained moderate levels, while envita.com and abecma.com showed varied trends. Cityofhope.org experienced significant spikes, notably on the 10th and 20th. Her2know.com and her2empowered.com had consistent activity, with mmissionpossible.com peaking mid-month. The month concluded with breyanzi.com leading in impressions.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Oncology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
  1. 1
    RR Multiple Myeloma - Read Treatment Outcomes Prescription treatment website

    Find Helpful Resources And Safety Information For Treating Relapsed Multiple Myeloma.

  2. 2
    What is CAR T-Cell Therapy? | Learn About CAR T-Cell Therapy Prescription treatment website

    CAR T-Cell Therapy Helps Your Immune System Fight Against Certain Relapsed Blood Cancers.

  3. 3
    Visit the HCP Website | Car-T for Multiple Myeloma https://www.mmissionpossible.com

    Learn how ongoing research on novel binding domains can impact the future of BCMA Therapy.

  4. 4
    Learn More About HR+/HER2+ mBC http://www.stepsforher.com

    HR+/HER2+ BC Subtype — Visit A Physician Website for Information on HR+/HER2+ Metastatic Breast Cancer. Find Out More About the Mechanism of Bidirectional Crosstalk in HR+/HER2+ mBC Disease.

  5. 5
    What is Triple Negative BC? - Triple Negative Breast Cancer https://www.tnbcfoundation.org

    Access TNBC resources for patients & caregivers to assist before, during & after treatment. Our...

Copyright © Adthena. All rights reserved.

In the competitive landscape of oncology PPC ads, five top performers emerge, each with a unique narrative. Abecma.com focuses on relapsed multiple myeloma, offering resources and safety information. Letschatcart.com educates on CAR T-Cell Therapy, highlighting its role in combating relapsed blood cancers. Mmissionpossible.com delves into BCMA Therapy research, while Stepsforher.com provides insights on HR+/HER2+ metastatic breast cancer. Lastly, TNBCfoundation.org supports triple-negative breast cancer patients and caregivers, emphasizing comprehensive care. These ads collectively underscore the importance of education, support, and cutting-edge research in oncology.

Frequently Asked Questions

Customer Success Stories

the7stars Case study: PPC campaign Optimization

the7stars case study: Achieving Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study
Sage Case study: Brand protection strategy

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.